Europe

The simplest way to get overseas exposure is to buy an all-in-one global balanced fund that makes the allocation decisions for you.

Barron’s picked Schneider Electric in October 2024. Things haven’t worked out—yet.

The food processor will be acquired by Investindustrial, a European investment firm.

The deal to acquire Northern Data will allow Rumble to obtain more than 40,000 Nvidia graphics processing units.

The Dutch government’s repossession of auto chip powerhouse Nexperia from its Chinese parent looks to be spreading pain across the auto industry.

The chip designer is generating higher royalty rates and is making progress in the cloud-server processor market.

The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

Norway’s $1.9 trillion dollar sovereign-wealth fund voted against Elon Musk’s trillion-dollar pay package. That could make some investors nervous.

Spotify stock fell even though it increased its monthly active users by 11% to 713 million, topping the company’s prior guidance of 710 million.

The Italian supercar maker is bidding to drum up some enthusiasm following an electric-vehicle reveal that didn't quite go to plan.

Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.

Euro zone inflation has been running close to 2% for months now, which is good news for the European Central Bank.

Nvidia’s stake will boost the Finnish company’s ability to build connectivity solutions for AI.

The credit-rating firm sent a warning to the nation, which had recently been lowered by S&P.

Some analysts are avoiding the European bank sector’s better known large-cap names. Instead, they are looking at KBC Group or Erste Group.

The U.S. is seeking leverage in its trade negotiations with China.

President Donald Trump imposed sanctions on Russian oil producers Rosneft and Lukoil.

Revenue in the all-important cloud unit was lower than expected.

The board turmoil represents a breakdown in relations between the company and its controlling shareholder.

China will make the moves that decide whether the war escalates or draws down, Ram Charan writes in a guest commentary.

Trump told reporters late Thursday that the list price of Ozempic, which he called “the fat loss drug,” will be “much lower.”

The world has better alternatives to what Beijing is offering, John Austin writes in a guest commentary.

France is an underappreciated export powerhouse whose listed companies reap three-quarters of their sales beyond its borders. Of the top 10 names in the index, only BNP Paribas could be considered domestic-facing.

The cuts are across regions and job functions, the Swiss food company says.

ASML stock has been on an impressive run as investors bet it will benefit from the AI chip boom.